Welcome to Gaia! ::

mad

question question

idea

Factors to Note for A’s Q1 Earnings
Agilent’s first-quarter fiscal 2025 performance is expected to have been affected by two percentage points by the timing of the Lunar New Year.

The company’s first-quarter fiscal 2025 free cash flow is expected to have declined marginally, led by higher capital expenditure than the prior year. This increase in spending reflects the completion of significant investment levels for the NASD expansion, particularly for Trains C and D, which is likely to have affected its growth in the quarter under review.

In the first quarter of fiscal 2025, profitability is expected to have come under pressure due to lower revenues, while expenses are typically higher during this period. This increase in expenses is likely to have been partly driven by merit resets and contributed to elevated expense levels.

Agilent is expected to have faced headwinds from a slowing global economy and geopolitical uncertainties, especially in China, a key market for the company. These challenges are likely to have weighed on demand and operational efficiency in the first quarter of 2025.

A’s fourth-quarter book-to-bill ratio exceeded 1, reflecting a strong order pipeline and steady market improvement. This positive trend signals sustained demand, which is expected to have benefited Agilent in the to-be-reported quarter.

The company's acquisition of BIOVECTRA is set to have enhanced its Contract Development and Manufacturing Organization business, particularly in oligonucleotides and CRISPR therapeutics. This move is anticipated to have expanded the company's service offerings in peptide synthesis, driving revenue growth in the first quarter of 2025.

What Our Model Says
According to the Zacks model, the combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the exact case here.

A has an Earnings ESP of 0.00% and a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

question

idea idea

Zacks Investment Research rates stocks from #1 (Strong Buy) to #5 (Strong Sell), with #1 stocks being the top 5% with the most potential. As of February 24, 2025, the exact list of current #1 Rank Strong Buy stocks isn't fully publicly available without a subscription. However, based on recent additions reported in their commentary articles, we can compile a list of 20 stocks that were added in early February 2025, which likely includes many current #1 Rank stocks. Note that some may have been removed, as Zacks updates rankings daily based on earnings estimate revisions.
Compiled List
Here’s the list of stocks recently added to the #1 Rank, which are likely part of the current Strong Buy list:
ALGT (Allegiant Travel Company)
NFG (National Fuel Gas Company)
SNEX (StoneX Group Inc.)
UTI (Universal Technical Institute, Inc.)
CURB (CuriosityStream Inc.)
FRSH (Freshworks Inc.)
SFTBY (SoftBank Group Corp.)
ATGE (Adtalem Global Education Inc.)
FINW (FinWise Bancorp)
PAHC (Physicians Realty Trust)
PFIS (Peoples Financial Services Corp.)
TAP (Molson Coors Beverage Company)
NMRK (Newmark Group, Inc.)
URBN (Urban Outfitters, Inc.)
ATEYY (Atlas Copco AB)
BHRB (Burke & Herbert Financial Services Corp.)
ACB (Aurora Cannab is Inc.)
MWA (Mueller Water Products, Inc.)
BJ (BJ's Wholesale Club Holdings, Inc.)
PRTH (Prothena Corporation)
This list is based on public articles from early February, but it’s important to check Zacks' official site for the most accurate and up-to-date information, as stocks can be added or removed daily.
Unexpected Detail
An unexpected detail is that Tesla (TSLA), often a high-profile stock, is currently ranked #5 (Strong Sell) by Zacks, not #1, showing how rankings can differ from market popularity.